1.54 USD
▼-0.06-3.75%
盘后 1.53 -0.65%
2026-09-15
市值
$158.28M
市盈率
—
EPS
-2.47
股息率
—
52 周区间
1.26 – 6.88
成交量
64.30K
Beta
0.96
目标价
4.33
52W 低 1.2652W 高 6.88
价格走势
公司简介
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.